Safety, Tolerability, and Pharmacokinetics of Once-Monthly Oral Islatravir: A Phase 2a Study in Participants at Low Risk for Acquiring Human Immunodeficiency Virus Type 1. - Hillier SL; Bekker LG; Riddler SA; Hendrix CW; Badal-Faesen S; Macdonald P; Nair G; Lombaard J; Caraco Y; Peer A; Patel M; Vargo R; et al. (The Journal of infectious diseases, 2025)